ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants

Yan, Qihong; Hou, Ruitian; Huang, Xiaohan; Zhang, Yanjun; He, Ping; Zhang, Yudi; Liu, Banghui; Wang, Qian; Rao, Haiyue; Chen, Xianying; Zhao, Xinwei; Niu, Xuefeng; Zhao, Jincun*; Xiong, Xiaoli*; Chen, Ling*广州医学院; 中国科学院研究生院; 中国科学院; 1
Emerging Microbes & Infections2022-12-31DOI: 10.1080/22221751.2022.2140611
5被引7阅读
引用收藏
分享

摘要

SARS-CoV-2 variants continue to emerge facing established herd immunity. L452R, previously featured in the Delta variant, quickly emerged in Omicron subvariants, including BA.4/BA.5, implying a continued selection pressure on this residue. The underlying links between spike mutations and their selective pressures remain incompletely understood. Here, by analyzing 221 structurally characterized antibodies, we found that IGHV1-69-encoded antibodies preferentially contact L452 using germline-encoded hydrophobic residues at the tip of HCDR2 loop. Whereas somatic hypermutations or VDJ rearrangements are required to acquire L452-contacting hydrophobic residues for non-IGHV1-69 encoded antibodies. Antibody repertoire analysis revealed that IGHV1-69 L452-contacting antibody lineages are commonly induced among COVID-19 convalescents but non-IGHV1-69 encoded antibodies exhibit limited prevalence. In addition, we experimentally demonstrated that L452R renders most published IGHV1-69 antibodies ineffective. Furthermore, we found that IGHV1-69 L452-contacting antibodies are enriched in convalescents experienced Omicron BA.1 (without L452R) breakthrough infections but rarely found in Delta (with L452R) breakthrough infections. Taken together, these findings support that IGHV1-69 population antibodies contribute to selection pressure for L452 substitution. This study thus provides a better understanding of SARS-CoV-2 variant genesis and immune evasion.

学科与关键词

关键词
SARS-CoV-2L452RShared antibody responseImmune evasion
相关
加载中…
  • SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
    He, Ping; Liu, Banghui; Gao, Xijie; Yan, Qihong; Pei, Rongjuan; Sun, Jing; Chen, Qiuluan; Hou, Ruitian; Li, Zimu; Zhang, Yanjun; Zhao, Jincun; Sun, Hao; Feng, Bo; Wang, Qian; Yi, Haisu; Hu, Peiyu; Li, Pingchao; Zhang, Yudi; Chen, Zhilong; Niu, Xuefeng; Zhong, Xiaolin; Jin, Liang; Liu, Xiaofeng; Qu, Kun; Ciazynska, Katarzyna A.; Carter, Andrew P.; Briggs, John A. G.; Chen, Jizheng; Liu, Jinsong; Chen, Xinwen*; He, Jun*; Chen, Ling; Xiong, XiaoliNature Microbiology, 2022, 7(10): 1635-+.被引 18
  • Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents
    Yan, Qihong; Zhang, Yudi; Hou, Ruitian; Pan, Wenjing; Liang, Huan; Gao, Xijie; Deng, Weiqi; Huang, Xiaohan; Qu, Linbing; Tang, Congli; He, Ping; Liu, Banghui; Wang, Qian; Zhao, Xinwei; Lin, Zihan; Chen, Zhaoming; Li, Pingchao; Han, Jian; Xiong, Xiaoli*; Zhao, Jincun; Li, Song; Niu, Xuefeng; Chen, Ling*Emerging Microbes & Infections, 2024, 13(1): 2290841.
  • Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants
    Yu, Haisheng; Liu, Banghui; Zhang, Yudi; Gao, Xijie; Wang, Qian; Xiang, Haitao; Peng, Xiaofang; Xie, Caixia; Wang, Yaping; Hu, Peiyu; Shi, Jingrong; Shi, Quan; Zheng, Pingqian; Feng, Chengqian; Tang, Guofang; Liu, Xiaopan; Guo, Liliangzi; Lin, Xiumei; Li, Jiaojiao; Liu, Chuanyu; Huang, Yaling; Yang, Naibo; Chen, Qiuluan; Li, Zimu; Su, Mengzhen; Yan, Qihong; Pei, Rongjuan; Chen, Xinwen; Liu, Longqi; Hu, Fengyu; Liang, Dan; Ke, Bixia; Ke, Changwen; Li, Feng; He, Jun; Wang, Meiniang; Chen, LingNature Communications, 2023, 14(1): 1058.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Emerging Microbes & Infections
发表日期
2022-12-31
卷期
第 11 卷, 第 1 期
页码
2749-2761
DOI
10.1080/22221751.2022.2140611
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82201932, 82041014, 82061138006]

作者

  • Y

    Yan, Qihong (第一作者)

    1 · guangzhou med univ · chinese acad sci · guangzhou inst biomed & hlth

  • H

    Hou, Ruitian

    chinese acad sci · guangzhou inst biomed & hlth · univ chinese acad sci

查看全部 15 位作者收起作者
  • H

    Huang, Xiaohan

    univ chinese acad sci · chinese acad sci · guangzhou inst biomed & hlth

  • Z

    Zhang, Yanjun

    1 · guangzhou med univ

  • H

    He, Ping

    chinese acad sci · guangzhou inst biomed & hlth · univ chinese acad sci

  • Z

    Zhang, Yudi

    chinese acad sci · guangzhou inst biomed & hlth · univ chinese acad sci

  • L

    Liu, Banghui

    chinese acad sci · guangzhou inst biomed & hlth

  • W

    Wang, Qian

    1 · guangzhou med univ

  • R

    Rao, Haiyue

    1 · guangzhou med univ

  • C

    Chen, Xianying

    1 · guangzhou med univ

  • Z

    Zhao, Xinwei

    chinese acad sci · guangzhou inst biomed & hlth

  • N

    Niu, Xuefeng

    1 · guangzhou med univ

  • Z

    Zhao, Jincun (通讯)

    1 · guangzhou med univ

  • X

    Xiong, Xiaoli (通讯)

    chinese acad sci · guangzhou inst biomed & hlth

  • C

    Chen, Ling (通讯)

    1 · guangzhou med univ · chinese acad sci · guangzhou inst biomed & hlth

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417